4 results match your criteria: "From the Los Angeles LGBT Center[Affiliation]"
Are Centers for Disease Control and Prevention Guidelines for Preexposure Prophylaxis Specific Enough? Formulation of a Personalized HIV Risk Score for Pre-Exposure Prophylaxis Initiation.
Sex Transm Dis
January 2017
From the *Los Angeles LGBT Center; †Division of Infectious Diseases, David Geffen School of Medicine, ‡Department of Biostatistics, Fielding School of Public Health, §Department of Community Health Sciences, Fielding School of Public Health, ¶Anderson School of Business, and ∥Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, Los Angeles, CA.
Background: Preexposure prophylaxis (PrEP) has emerged as a human immunodeficiency virus (HIV) prevention tool for populations at highest risk for HIV infection. Current US Centers for Disease Control and Prevention (CDC) guidelines for identifying PrEP candidates may not be specific enough to identify gay, bisexual, and other men who have sex with men (MSM) at the highest risk for HIV infection. We created an HIV risk score for HIV-negative MSM based on Syndemics Theory to develop a more targeted criterion for assessing PrEP candidacy.
View Article and Find Full Text PDFDoxycycline prophylaxis to reduce incident syphilis among HIV-infected men who have sex with men who continue to engage in high-risk sex: a randomized, controlled pilot study.
Sex Transm Dis
February 2015
From the *Los Angeles LGBT Center (The Center), Los Angeles, CA; and †Department of Community Health Sciences, Fielding School of Public Health, ‡Department of Biostatistics, Fielding School of Public Health, §Luskin School of Public Affairs, and ¶Geffen School of Medicine, University of California, Los Angeles.
Background: Incident syphilis infections continue to be especially prevalent among a core group of HIV-infected men who have sex with men (MSM). Because of synergy between syphilis and HIV infections, innovative means for controlling incident syphilis infections are needed.
Methods: Thirty MSM who had syphilis twice or more since their HIV diagnosis were randomized to receive either daily doxycycline prophylaxis or contingency management (CM) with incentive payments for remaining free of sexually transmitted diseases (STDs).
Evaluation of gonorrhea test of cure at 1 week in a Los Angeles community-based clinic serving men who have sex with men.
Sex Transm Dis
October 2014
From the *Los Angeles LGBT Center, Los Angeles, CA; †Department of Community Health Sciences, Fielding School of Public Health, University of California, Los Angeles, CA; ‡Division of STD Prevention (NCCHSTP), Centers for Disease Control and Prevention, Epidemiology and Surveillance Branch, Atlanta, GA; and §County of Los Angeles, Department of Public Health, Los Angeles, CA.
Background: Because of the decreasing susceptibility of Neisseria gonorrhoeae to cephalosporin therapy, the Centers for Disease Control and Prevention recommends test of cure (TOC) 1 week after gonorrhea (GC) treatment if therapies other than ceftriaxone are used. In addition, the Centers for Disease Control and Prevention asks clinicians, particularly those caring for men who have sex with men (MSM) on the west coast, to consider retesting all MSM at 1 week. However, it is unclear if this is acceptable to providers and patients or if nucleic acid amplification tests (NAATs) are useful for TOC at 7 days.
View Article and Find Full Text PDF